Together we are beating cancer

Donate now

Neuroendocrine tumour (NET)

Showing 1 out of 1 results
Cancer Research UK logo

Counting the number of cancer cells in blood samples taken before and after treatment for advanced neuroendocrine tumours could provide a 'snapshot' of how well patients are responding within weeks of starting treatment, according to results from a study being presented at the American Society for Clinical Oncology cancer conference today (Monday). Counting the number of cancer cells in blood samples taken before and after treatment for advanced neuroendocrine tumours could provide a 'snapshot' of how well patients are responding within weeks of starting treatment, according to results from a study being presented at the American Society for Clinical Oncology cancer conference today (Monday).

by Cancer Research UK | News | 4 June 2012

4 June 2012